Cite

HARVARD Citation

    Ayvaci, M. et al. (2013). Cost-Effectiveness of Adjuvant FOLFOX and 5FU/LV Chemotherapy for Patients with Stage II Colon Cancer. Medical decision making. pp. 521-532. [Online]. 
  
Back to record